TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TNFRSF receptor-specific antibody fusion proteins with targeting controlled FcγR-independent agonistic activity
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 3, Pages -
Publisher
Springer Nature
Online
2019-03-04
DOI
10.1038/s41419-019-1456-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative analysis of cell surface antigen-antibody interaction using Gaussia princeps luciferase antibody fusion proteins
- (2017) Juliane Kums et al. mAbs
- Denosumab: Current Use in the Treatment of Primary Bone Tumors
- (2017) Olga D. Savvidou et al. ORTHOPEDICS
- Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
- (2016) Martin Chopra et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Principles of antibody-mediated TNF receptor activation
- (2015) H Wajant CELL DEATH AND DIFFERENTIATION
- Binding Studies of TNF Receptor Superfamily (TNFRSF) Receptors on Intact Cells
- (2015) Isabell Lang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity
- (2014) A. Krippner-Heidenreich et al. JOURNAL OF IMMUNOLOGY
- CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants
- (2014) J Trebing et al. Cell Death & Disease
- TNF Receptor-Associated Factor 1 is a Major Target of Soluble TWEAK
- (2014) José Antonio Carmona Arana et al. Frontiers in Immunology
- Denosumab in osteoporosis
- (2013) Dima L Diab et al. Expert Opinion On Drug Safety
- Fibroblast Growth Factor Inducible (Fn14)-specific Antibodies Concomitantly Display Signaling Pathway-specific Agonistic and Antagonistic Activity
- (2013) Steffen Salzmann et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A novel llama antibody targeting Fn14 exhibits anti-metastatic activity in vivo
- (2013) Johannes Trebing et al. mAbs
- Antitumor activities of agonistic anti-TNFR antibodies require differential Fc RIIB coengagement in vivo
- (2013) F. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Properties of mouse and human IgG receptors and their contribution to disease models
- (2012) P. Bruhns BLOOD
- A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potency
- (2012) M Chodorge et al. CELL DEATH AND DIFFERENTIATION
- Apoptotic and antitumor activity of death receptor antibodies require inhibitory Fc receptor engagement
- (2012) F. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
- (2011) B. B. Aggarwal et al. BLOOD
- An Fcγ Receptor-Dependent Mechanism Drives Antibody-Mediated Target-Receptor Signaling in Cancer Cells
- (2011) Nicholas S. Wilson et al. CANCER CELL
- Engineering death receptor ligands for cancer therapy
- (2011) Harald Wajant et al. CANCER LETTERS
- Bypassing glycosylation: engineering aglycosylated full-length IgG antibodies for human therapy
- (2011) Sang Taek Jung et al. CURRENT OPINION IN BIOTECHNOLOGY
- Interaction with Fc RIIB Is Critical for the Agonistic Activity of Anti-CD40 Monoclonal Antibody
- (2011) A. L. White et al. JOURNAL OF IMMUNOLOGY
- Inhibitory Fc Receptor Engagement Drives Adjuvant and Anti-Tumor Activities of Agonistic CD40 Antibodies
- (2011) F. Li et al. SCIENCE
- Soluble and Transmembrane TNF-Like Weak Inducer of Apoptosis Differentially Activate the Classical and Noncanonical NF- B Pathway
- (2010) C. Roos et al. JOURNAL OF IMMUNOLOGY
- Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways
- (2009) Daniela Berg et al. FEBS Journal
- Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)
- (2009) Hilka Rauert et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Trimer Stabilization, Oligomerization, and Antibody-Mediated Cell Surface Immobilization Improve the Activity of Soluble Trimers of CD27L, CD40L, 41BBL, and Glucocorticoid-Induced TNF Receptor Ligand
- (2009) A. Wyzgol et al. JOURNAL OF IMMUNOLOGY
- Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilization
- (2008) Nicole Müller et al. FEBS Journal
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started